Abstract:Summary
Curli are extracellular functional amyloids that are assembled by enteric bacteria during biofilm formation and host colonization. An efficient secretion system and chaperone network ensures that the major curli fiber subunit, CsgA, does not form intracellular amyloid aggregates. We discovered that the periplasmic protein CsgC was a highly effective inhibitor of CsgA amyloid formation. In the absence of CsgC, CsgA formed toxic intracellular aggregates. In vitro, CsgC inhibited CsgA amyloid formation at… Show more
“…Its production is correlated with the other components of the Csg system (56), and it likely functions as a specific anti-amyloid chaperone in the production of curli fibers. Interestingly, CsgC was found to inhibit amyloid formation not only of CsgA, but also the Parkinson-associated ␣-synuclein, while not affecting the aggregation of the highly amyloidogenic A peptide (57). In contrast, for the BRICHOS domain, it appears to be the other way around; it efficiently reduces A aggregation and toxicity (see above), whereas it only marginally inhibits ␣-synuclein aggregation.…”
Section: Chaperones In the Regulation Of Functional Amyloidsmentioning
confidence: 99%
“…Instead, the preferred target sequence for CsgC was identified as a DQWXGKNSE motif located at the end of repeat 3 of CsgA. However, the glutamine-and asparagine-rich segments in other repeats as well as in CsgB may also be recognized (57). CsgC contains a high number of glutamine residues evenly distributed on its surface (Fig.…”
Section: Insights Into the Molecular Mechanism Of The Csgc Chaperonementioning
Many proteins can form amyloid-like fibrils in vitro, but only about 30 amyloids are linked to disease, whereas some proteins form physiological amyloid-like assemblies. This raises questions of how the formation of toxic protein species during amyloidogenesis is prevented or contained in vivo. Intrinsic chaperoning or regulatory factors can control the aggregation in different protein systems, thereby preventing unwanted aggregation and enabling the biological use of amyloidogenic proteins. The molecular actions of these chaperones and regulators provide clues to the prevention of amyloid disease, as well as to the harnessing of amyloidogenic proteins in medicine and biotechnology.
“…Its production is correlated with the other components of the Csg system (56), and it likely functions as a specific anti-amyloid chaperone in the production of curli fibers. Interestingly, CsgC was found to inhibit amyloid formation not only of CsgA, but also the Parkinson-associated ␣-synuclein, while not affecting the aggregation of the highly amyloidogenic A peptide (57). In contrast, for the BRICHOS domain, it appears to be the other way around; it efficiently reduces A aggregation and toxicity (see above), whereas it only marginally inhibits ␣-synuclein aggregation.…”
Section: Chaperones In the Regulation Of Functional Amyloidsmentioning
confidence: 99%
“…Instead, the preferred target sequence for CsgC was identified as a DQWXGKNSE motif located at the end of repeat 3 of CsgA. However, the glutamine-and asparagine-rich segments in other repeats as well as in CsgB may also be recognized (57). CsgC contains a high number of glutamine residues evenly distributed on its surface (Fig.…”
Section: Insights Into the Molecular Mechanism Of The Csgc Chaperonementioning
Many proteins can form amyloid-like fibrils in vitro, but only about 30 amyloids are linked to disease, whereas some proteins form physiological amyloid-like assemblies. This raises questions of how the formation of toxic protein species during amyloidogenesis is prevented or contained in vivo. Intrinsic chaperoning or regulatory factors can control the aggregation in different protein systems, thereby preventing unwanted aggregation and enabling the biological use of amyloidogenic proteins. The molecular actions of these chaperones and regulators provide clues to the prevention of amyloid disease, as well as to the harnessing of amyloidogenic proteins in medicine and biotechnology.
“…Associated with this pore are the CsgE and CsgF proteins, which modulate subunit stability and proper assembly of curli fibers (18,19). The periplasmic protein CsgC may be involved in regulating the export of curli subunits through the regulation of the redox state of CsgG (20), and it was shown to inhibit CsgA amyloid formation in vitro (21). CsgD is the master regulator that controls at the transcriptional level the expression of the csgBAC operon and also adrA, which is involved in posttranscriptional regulation of cellulose synthesis and encodes another common component of the biofilm matrix (22)(23)(24)(25).…”
Section: Amyloid Structures With Dedicated Fiber Assembly Machinerymentioning
confidence: 99%
“…This gives us the clue that compounds able to inhibit human aberrant amyloids could be active also against bacterial functional amyloids and vice versa. In this regard, it has been recently reported that the periplasmic protein CsgC is highly effective in inhibiting human ␣-synuclein and CsgA amyloid formation, while it does not affect polymerization of A 42 (21).…”
Section: Amyloids As Targets To Fight Against Biofilmsmentioning
bRecent insights into bacterial biofilm matrix structures have induced a paradigm shift toward the recognition of amyloid fibers as common building block structures that confer stability to the exopolysaccharide matrix. Here we describe the functional amyloid systems related to biofilm matrix formation in both Gram-negative and Gram-positive bacteria and recent knowledge regarding the interaction of amyloids with other biofilm matrix components such as extracellular DNA (eDNA) and the host immune system. In addition, we summarize the efforts to identify compounds that target amyloid fibers for therapeutic purposes and recent developments that take advantage of the amyloid structure to engineer amyloid fibers of bacterial biofilm matrices for biotechnological applications.
“…Although CsgA is prone to aggregation and forms amyloid fibers in vitro (2,27), the formation of curli fibers in vivo is nucleated by CsgB (28)(29)(30). CsgC exists in periplasm and is an effective inhibitor of CsgA polymerization, suppressing fibrilization at substoichiometric ratios as low as 1:500 (CsgC:CsgA) (31), and perhaps preventing premature periplasmic amyloid formation and toxicity to the bacterium.…”
Curli, consisting primarily of major structural subunit CsgA, are functional amyloids produced on the surface of Escherichia coli, as well as many other enteric bacteria, and are involved in cell colonization and biofilm formation. CsgE is a periplasmic accessory protein that plays a crucial role in curli biogenesis. CsgE binds to both CsgA and the nonameric pore protein CsgG. The CsgG-CsgE complex is the curli secretion channel and is essential for the formation of the curli fibril in vivo. To better understand the role of CsgE in curli formation, we have determined the solution NMR structure of a double mutant of CsgE (W48A/F79A) that appears to be similar to the wild-type (WT) protein in overall structure and function but does not form mixed oligomers at NMR concentrations similar to the WT. The well-converged structure of this mutant has a core scaffold composed of a layer of two α-helices and a layer of three-stranded antiparallel β-sheet with flexible N and C termini. The structure of CsgE fits well into the cryoelectron microscopy density map of the CsgG-CsgE complex. We highlight a striking feature of the electrostatic potential surface in CsgE structure and present an assembly model of the CsgG-CsgE complex. We suggest a structural mechanism of the interaction between CsgE and CsgA. Understanding curli formation can provide the information necessary to develop treatments and therapeutic agents for biofilm-related infections and may benefit the prevention and treatment of amyloid diseases. CsgE could establish a paradigm for the regulation of amyloidogenesis because of its unique role in curli formation.biofilm formation | intrinsically disordered protein | aggregation | protein-protein interaction | CsgG
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.